You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
DILATREND is indicated for the treatment of mild to moderate hypertension. Data have not been provided to support the use of this drug in severe hypertension or renovascular disease. DILATREND is indicated for the treatment of patients with symptomatic mild to moderate (NYHA class II & III) congestive heart failure, as an adjunct to conventional treatments (e.g diuretics, digoxin, ACE inhibitors and vasodilators). INDICATIONS AS AT 24 JANUARY 2002: DILATREND is indicated for the treatment of mild to moderate hypertension. Data have not been provided to support the use of this drug in severe hypertension or renovascular disease. DILATREND is indicated for the treatment of patients with symptomatic mild to severe (NYHA Class II - IV) congestive heart failure (CHF) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ACE inhibitors and vasodilators). INDICATIONS AS AT 3 MARCH 2003: DILATREND is indicated for the treatment of hypertension. Data have not been provided to support the use of this drug in renovascular disease. DILATREND is indicated for the treatment of patients with symptomatic mild to severe (NYHA Class II - IV) congestive heart failure (CHF) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ACE inhibitors and vasodilators).
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
DILATREND is indicated for the treatment of mild to moderate hypertension. Data have not been provided to support the use of this drug in severe hypertension or renovascular disease. DILATREND is indicated for the treatment of patients with symptomatic mild to moderate (NYHA class II & III) congestive heart failure, as an adjunct to conventional treatments (e.g diuretics, digoxin, ACE inhibitors and vasodilators). INDICATIONS AS AT 24 JANUARY 2002: DILATREND is indicated for the treatment of mild to moderate hypertension. Data have not been provided to support the use of this drug in severe hypertension or renovascular disease. DILATREND is indicated for the treatment of patients with symptomatic mild to severe (NYHA Class II - IV) congestive heart failure (CHF) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ACE inhibitors and vasodilators). INDICATIONS AS AT 3 MARCH 2003: DILATREND is indicated for the treatment of hypertension. Data have not been provided to support the use of this drug in renovascular disease. DILATREND is indicated for the treatment of patients with symptomatic mild to severe (NYHA Class II - IV) congestive heart failure (CHF) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ACE inhibitors and vasodilators).
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
DILATREND is indicated for the treatment for the treatment of mild to moderate hypertension. Data have not been provided to support the use of this drug in severe hypertension or renovascular disease. DILATREND is indicated for the treatment of patients with symptomatic mild to moderate (NYHA class II & III) congestive heart failure, as an adjunct to conventional treatments (e.g diuretics, digoxin, ACE inhibitors and vasodilators). INDICATIONS AS AT 24 JANUARY 2002: DILATREND is indicated for the treatment of mild to moderate hypertension. Data have not been provided to support the use of this drug in severe hypertension or renovascular disease. DILATREND is indicated for the treatment of patients with symptomatic mild to severe (NYHA Class II - IV) congestive heart failure (CHF) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ACE inhibitors and vasodilators). INDICATIONS AS AT 3 MARCH 2003: DILATREND is indicated for the treatment of hypertension. Data have not been provided to support the use of this drug in renovascular disease. DILATREND is indicated for the treatment of patients with symptomatic mild to severe (NYHA Class II - IV) congestive heart failure (CHF) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ACE inhibitors and vasodilators).
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
